Ditchcarbon
  • Contact
  1. Organizations
  2. Cencora, Inc.
Public Profile
Medical Device Manufacturing
US
updated 6 days ago

Cencora, Inc.

Company website

Cencora, Inc., headquartered in the United States, is a prominent player in the global pharmaceutical and life sciences industry. Founded in 2022, the company has quickly established itself as a leader in providing comprehensive supply chain solutions, clinical trial services, and logistics for biopharmaceutical products. With a strong operational presence across North America, Europe, and Asia, Cencora is dedicated to enhancing patient access to innovative therapies. Cencora's unique offerings include temperature-controlled logistics and tailored distribution services, ensuring the integrity of sensitive products throughout the supply chain. The company’s commitment to quality and efficiency has earned it a notable position in the market, recognised for its ability to streamline processes and reduce time-to-market for critical medications. As Cencora continues to grow, it remains focused on delivering exceptional value to its partners and clients in the ever-evolving healthcare landscape.

DitchCarbon Score

How does Cencora, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

42

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Cencora, Inc.'s score of 42 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.

65%

Let us know if this data was useful to you

Cencora, Inc.'s reported carbon emissions

In 2024, Cencora, Inc. reported total carbon emissions of approximately 135,087,000 kg CO2e for Scope 1, 88,699,000 kg CO2e for Scope 2 (market-based), and a significant 40,504,539,000 kg CO2e for Scope 3 emissions. This reflects a comprehensive approach to emissions reporting, covering all three scopes of greenhouse gas emissions. Cencora has set ambitious climate commitments, aiming for a 54.6% reduction in absolute Scope 1 and 2 greenhouse gas emissions by FY2032, using FY2019 as the baseline. Additionally, the company has pledged that 82% of its suppliers by spend will have science-based targets by FY2027. These targets align with the Science Based Targets initiative (SBTi) and are designed to support the global effort to limit warming to 1.5°C. Furthermore, Cencora is committed to achieving net zero emissions by 2050 for both Scope 1 and Scope 2 emissions, demonstrating a long-term vision for sustainability. The company's proactive stance on climate action is indicative of its commitment to reducing its environmental impact within the healthcare sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20192024
Scope 1
98,742,000
000,000,000
Scope 2
110,191,000
00,000,000
Scope 3
19,881,916,000
00,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cencora, Inc.'s primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Cencora, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Cencora, Inc. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

OptumRx, Inc.

US
•
Health and social work services (85)
Updated 14 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Mckesson

CA
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251024.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy